Page 3 - Linical Evolution News Today

A small molecule oral treatment for breast cancer has been granted fast-track designation by the US Food and Drug Administration (FDA).

With independent pharmacies now facing significant challenges, healthcare SaaS provider Charac was pleased to announce more investment so it can accelerate a digitization drive.

Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more frequently. Naturally with more and more people using it for work, new regulations on data use and management are starting to appear.

A husband-and-wife team keen to find a solution to an ‘NHS in crisis’ have secured $1.5 million in seed funding for their UK-based startup providing AI-powered clinical and drug prescription services for minor conditions.

Carolina is responsible for the consulting department at Genesis Packaging Technologies where she designs package characterization studies.

Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.

Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.

Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more frequently. Naturally with more and more people using it for work, new regulations on data use and management are starting to appear.

Colleen Acosta is CEO of Freya Biosciences which is a trans-Atlantic clinical-stage biotech company pioneering microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of women’s reproductive system conditions and we were excited to put our Women in Science questions to her.

OM1 says it wants to stand at the helm of a healthcare revolution, fostering an integrated approach to generating and utilizing real-world evidence (RWE), reshaping the foundation of healthcare.